California Public Employees Retirement System’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.85M Buy
35,348
+423
+1% +$122K 0.01% 889
2025
Q4
$10.6M Buy
34,925
+1,376
+4% +$429K 0.01% 882
2025
Q3
$9.41M Buy
33,549
+1,352
+4% +$368K 0.01% 939
2025
Q2
$7.77M Sell
32,197
-1,283
-4% -$303K 0.01% 950
2025
Q1
$8.15M Buy
33,480
+1,330
+4% +$400K 0.01% 911
2024
Q4
$10.6M Buy
32,150
+1,048
+3% +$356K 0.01% 852
2024
Q3
$10.4M Sell
31,102
-10,394
-25% -$3.3M 0.01% 884
2024
Q2
$11.3M Buy
41,496
+1,349
+3% +$392K 0.01% 818
2024
Q1
$13.9M Sell
40,147
-740
-2% -$243K 0.01% 751
2023
Q4
$13.2M Sell
40,887
-487
-1% -$153K 0.01% 765
2023
Q3
$14.8M Hold
41,374
0.01% 694
2023
Q2
$15.7M Sell
41,374
-103,591
-71% -$42.2M 0.01% 687
2023
Q1
$69.4M Sell
144,965
-8,856
-6% -$4.15M 0.06% 301
2022
Q4
$64.7M Sell
153,821
-6,926
-4% -$2.8M 0.06% 329
2022
Q3
$67.1M Sell
160,747
-2,262
-1% -$1.13M 0.06% 302
2022
Q2
$80.7M Sell
163,009
-2,696
-2% -$1.4M 0.08% 249
2022
Q1
$93.3M Sell
165,705
-3,445
-2% -$2.08M 0.07% 260
2021
Q4
$128M Sell
169,150
-1,873
-1% -$1.4M 0.09% 221
2021
Q3
$128M Buy
171,023
+919
+0.5% +$688K 0.1% 211
2021
Q2
$110M Sell
170,104
-1,835
-1% -$1.12M 0.08% 246
2021
Q1
$98.2M Sell
171,939
-4,007
-2% -$2.37M 0.07% 256
2020
Q4
$103M Buy
175,946
+127,187
+261% +$72.4M 0.08% 246
2020
Q3
$25.1M Buy
48,759
+1,257
+3% +$637K 0.02% 517
2020
Q2
$21.4M Sell
47,502
-103
-0.2% -$45.5K 0.02% 529
2020
Q1
$16.7M Sell
47,605
-2,400
-5% -$882K 0.02% 529
2019
Q4
$18.5M Buy
50,005
+4,845
+11% +$1.71M 0.02% 641
2019
Q3
$15M Buy
45,160
+11,928
+36% +$3.89M 0.01% 679
2019
Q2
$10.4M Sell
33,232
-8,782
-21% -$2.63M 0.01% 739
2019
Q1
$12.8M Sell
42,014
-13,096
-24% -$3.53M 0.02% 685
2018
Q4
$12.8M Buy
55,110
+1,649
+3% +$442K 0.02% 658
2018
Q3
$16.7M Buy
53,461
+212
+0.4% +$65.8K 0.02% 659
2018
Q2
$15.4M Buy
53,249
+1,450
+3% +$400K 0.02% 682
2018
Q1
$13M Sell
51,799
-10,719
-17% -$2.73M 0.02% 770
2017
Q4
$14.9M Buy
62,518
+1,961
+3% +$475K 0.02% 711
2017
Q3
$13.5M Buy
60,557
+2,118
+4% +$477K 0.02% 713
2017
Q2
$13.2M Buy
58,439
+600
+1% +$131K 0.02% 696
2017
Q1
$11.5M Buy
57,839
+900
+2% +$173K 0.02% 768
2016
Q4
$10.4M Buy
56,939
+300
+0.5% +$51.1K 0.02% 822
2016
Q3
$9.28M Sell
56,639
-1,700
-3% -$258K 0.02% 882
2016
Q2
$8.34M Sell
58,339
-4,400
-7% -$628K 0.01% 944
2016
Q1
$8.58M Sell
62,739
-2,500
-4% -$328K 0.01% 918
2015
Q4
$9.05M Hold
65,239
0.01% 904
2015
Q3
$8.76M Buy
65,239
+1,600
+3% +$230K 0.01% 895
2015
Q2
$9.59M Sell
63,639
-900
-1% -$129K 0.01% 933
2015
Q1
$7.39M Hold
64,539
0.01% 1137
2014
Q4
$7.39M Buy
64,539
+700
+1% +$80.6K 0.01% 1137
2014
Q3
$7.24M Buy
63,839
+1,000
+2% +$118K 0.01% 1140
2014
Q2
$7.52M Sell
62,839
-800
-1% -$97.7K 0.01% 1159
2014
Q1
$7.93M Sell
63,639
-400
-0.6% -$51.3K 0.01% 1078
2013
Q4
$7.93M Sell
64,039
-642
-1% -$78.2K 0.01% 1079
2013
Q3
$7.6M Buy
64,681
+2,078
+3% +$245K 0.01% 980
2013
Q2
$7.02M Buy
+62,603
New +$7.34M 0.01% 931

Other funds holding BIO